Ovarian Cancer GOG 262 - open only for pts on perfusion CT on ACRIN part of trial

March 13, 2013

Location: The Hospital of Central Connecticut

A Randomized Phase III Trial of Every 3 Weeks Paclitaxel versus Dose Dense Weekly Paclitaxel in Combination with Carboplatin with or without Concurrent and Consolidation Bevacizumab in the Treatment of Primary Stage III or IV Epithelial Ovarian, Peritoneal or Fallopian Tube Cancer and ACRIN 6695: Perfusion CT Imaging to Evaluate Treatment Response in Patients Participating in GOG-0262.